The Limited Times

Now you can see non-English news...

New Crown Vaccine|September will review whether the third dose Liu Yulong: the elderly and hospital staff need

2021-08-16T12:29:38.535Z


The new crown pneumonia vaccine program in Hong Kong has been in operation for nearly half a year. Recently, many people have discussed whether to vaccinate the third dose. The Scientific Committee of the Centre for Health Protection meets today (16th). Chairman of the Scientific Committee on Vaccine Preventable Diseases


The new crown pneumonia vaccine program in Hong Kong has been in operation for nearly half a year. Recently, many people have discussed whether to vaccinate the third dose.

The Scientific Committee of the Centre for Health Protection met today (16th). Liu Yulong, chairman of the Scientific Committee on Vaccine Preventable Diseases, said that he believes that the end of September will be the right time to review whether the special group of people need to receive the third dose of vaccine.

He emphasized that not everyone needs a third shot. In the case of BioNTech, only a small number of people need it, such as patients who are taking immune-suppressing drugs.


As far as Kexing is concerned, it is believed that the elderly and those at high risk need to be vaccinated, such as those who work in hospitals, airports, quarantine centers and other places.

Liu Yulong also believes that the current elderly vaccination rate is still low. "Neither the first cake nor the second cake has been made. What about the third one?"


▼On July 29, the community vaccination center will distribute same-day injections to the elderly▼


+1

Research refers to a 7-fold increase in the third dose of Kexing antibody

After the meeting, Liu Yulong said that there was no opportunity to discuss whether the third dose should be vaccinated at today's meeting. At present, data on the third dose is constantly appearing in various places. He believes that the end of September or October will be a suitable time for discussion.

In the case of Kexing, the study shows that 6 to 8 months after the two doses of elders over 60 years of age, the antibody dropped; after the third dose, the antibody level increased by 7 times, and the neutralizing antibody even increased to 300 or more.

However, he pointed out that the current vaccination rate for the elderly is still low, so the elderly should be encouraged to get vaccinated first.

He also emphasized that the death rate of elderly people infected with new coronary pneumonia is higher.

▼See the details of the scheduled vaccination and side effects of Kexing and BioNTech in the three pictures▼


Hospitals, quarantine centers and other staff also need a third dose

In addition, in addition to the elderly, he pointed out that people in high-risk groups may also be given a third shot, including those working in hospitals and quarantine centers.

He emphasized that if the group of people are infected with the new coronary pneumonia, the condition will not be serious, and the purpose of the third shot is to maintain the operation of the relevant premises.

For Fubitel, Liu Yulong pointed out that only a small number of people need the third shot, including those with low or impaired immunity, such as taking tight-immunity drugs.

He also reiterated that the two vaccines in the current Hong Kong vaccination plan are effective in preventing deaths and hospital admissions with an effective rate of 80% to 90%.

▼From July 8th, measures to maintain social distancing generally under the framework of the "vaccine bubble"▼


+15

Covid-19 vaccine | Cumulative vaccination rate: 54.8% Only 11,700 people made appointments in a single day, a new low for nearly three months 54.4% The number of appointments for vaccination by about 13,000 dropped for 4 consecutive days. New crown vaccines | Elderly misunderstandings lead to low vaccination rates. Experts urged flu shots and chronic patients to get new crown vaccines.

01News

Source: hk1

All news articles on 2021-08-16

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.